QuantumScape (NYSE:QS) stock may very well start soaring on the development of solid-state batteries and the company’s underlying innovation. Source: Michael Vi / Shutterstock.com Electric vehicles are the future. A commonly repeated mantra, it’s become such a meme that expressing a contrarian argument is sure to generate heat. However, some components of EVs are challenging,
With its massive price decline so far this year, is now the time to follow the crowd’s changing diagnosis on Teladoc (NYSE:TDOC)? Not so fast. TDOC stock may be down more than 25% year-to-date, and down about 50% from its all-time high of $308 per share. But despite this drop, and the fact it’s been trending
Jeff Bezos, left, and Elon Musk Getty Images; Reuters The U.S. Federal Court of Claims ruled against Jeff Bezos’ Blue Origin in the company’s lawsuit versus NASA over a lucrative astronaut lunar lander contract awarded to Elon Musk’s SpaceX earlier this year. Federal judge Richard Hertling sided with the defense in his ruling, completing a
In this article QCOM QRVO Medical syringe is seen with Moderna company logo displayed on a screen in the background in this illustration photo taken in Poland. Jakub Porzycki | NurPhoto | Getty Images Check out the companies making headlines in midday trading. Moderna — Moderna shares tumbled 19% after a weaker-than-expected quarterly report. The drug
Although all eyes have been on the searing path that benchmark equity indices have blazed in 2021, initial public offerings (IPOs) have had their own impressive bull market. In fact, Reuters reported in mid-June that U.S. IPOs hit an annual record in less than six months. So if 2020 was the year of the novel
You know a health savings account (HSA) helps pay for out-of-pocket medical costs, but it may surprise you to learn that this tax-advantaged account could be a superior retirement savings vehicle, too. It has become ingrained in us that we should max out our 401(k) or other workplace-defined contribution plan as the best way to
We highlight four ETFs that are benefitting from increasing adoption of automation & AI
The renewable energy industry is booming. While it only supplies less than a quarter of the power generated today, this will change drastically by 2040. Its share is expected to grow in excess of 40% by 2040, as new technologies are developed for wind and solar energy production. Therefore, in line with the fast-changing energy
Virgin Galactic (NYSE:SPCE) has been on a bad downward spiral. From a recent peak of $55.91 on June 25, SPCE stock is now near a low point of $19.55. However, despite this, don’t act on the urge just yet to bargain hunt in this stock. Source: rafapress / Shutterstock.com I forewarned investors that this could
In this article F CZR SHOO Ford CEO Jim Farley poses with the Ford F-150 Lightning pickup truck in Dearborn, Michigan, May 19, 2021. Rebecca Cook | Reuters It seems each passing trading session brings a torrent of quarterly earnings and sharp swings for the stocks of the companies reporting results. Positive prints can have
A worker wields hinges to the company’s largest commercial asphalt paver at the Calder Brothers’ facility in Taylors, South Carolina, U.S., July 19, 2021. Brandon Granger | Calder Brothers Corporation | Reuters Hiring is expected to have picked up at a solid pace and wages likely continued to climb in October, as Covid receded and
I first came in contact with Palantir (NYSE:PLTR) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past few months. The easiest opportunities came when it fell in sympathy to other small-cap stocks. Source: Ascannio / Shutterstock.com The problem with
It has been an excellent third-quarter earnings season so far. Of the S&P 500 stocks that have reported earnings, a majority have beaten analyst estimates. According to Factset Insight, 56% of the index companies have reported earnings so far in Q3 2021. Of those, 82% beat the consensus earnings per share (EPS). That’s higher than
Ocugen (NASDAQ:OCGN) is a stock that I continue to be wrong about. Over the past month, OCGN stock has gained more than 80%, greatly testing my patience. The stock has fallen from the $17 mark it reached this morning, but is still higher than I expected last month. Source: shutterstock.com/PhotobyTawat In my last article about
In this article MAXR A close look at the primary mirror of a Worldview Legion satellite during assembly and inspection. Maxar Maxar Technologies‘ stock jumped on Thursday after reporting third-quarter results, with Wall Street analysts welcoming the space company’s progress toward the launch of key satellites next year. The company reported an adjusted EBITDA profit
Workers at Stellantis’ Detroit Assembly plant which produces the new 2021 Grand Cherokee L, a new three-row SUV. Michael Wayland | CNBC Broad-based strength in hiring in October signals the economy is shaking off the Covid-related slump of the third quarter and could grow faster than expected in the fourth quarter. Employment increased by 531,000
When I last wrote about QuantumScape (NYSE:QS) in late September, I argued that if you could afford to lose it all, QS stock at $23.50 was in the buy zone. As I write this, it’s up 33% in the past month, trading above $30 for the first time since late June. Source: Michael Vi /
Key Takeaways Berkshire Hathaway beat analysts’ expectations on earnings and revenues but missed on operating earnings. Gains on its investment portfolio were down YOY, but operating earnings from all segments except insurance were up. Insurance posted a larger underwriting loss than in Q3 2020. Revenues increased YOY across business segments, reflecting the conglomerate’s broad exposure
Shares in Houston-based Tellurian (NYSEAMERICAN:TELL) have been riding the natural gas wave. Since mid-August, TELL stock has posted a 65% gain. It’s more than tripled its share price since the start of the year. However, despite rallying for the better part of three months, it remains well off its high close of $5.32 in June.
If you’ve read my prior articles on Ocugen (NASDAQ:OCGN), you know full well my heavily bearish view about OCGN stock. What’s the story here? The company is trying to bring Covaxin, a Covid-19 vaccine candidate developed by India’s Bharat Biotech, to the U.S. and Canada. Source: shutterstock.com/PhotobyTawat So far, it’s made little progress obtaining Emergency